Fundamental Data for VXGN

Enter Symbol

Overview

Community Research

Technical Charts

Related News

Blog Articles

Technicals

VAXGEN INC(OTC:VXGN)

VaxGen is the first and only company with AIDS vaccine candidates in Phase III trials, the final stage before regulatory approval can be sought.

# Employees: 216

Address: 349 Oyster Point Boulevard Suite 200,South San Francisco,CA,USA

Phone: 650-624-1000

Fax: 650-624-1001

Website: www.vaxgen.com

Email: ir@vaxgen.com

Sector: Medical

Industry: MED-DRUGS

Executive Officers

James P. Panek (Presi.; C.E.O.)

Randall L-w Caudil Phil. (Chmn.; Presi.)

Matthew J. Pfeffer (Sr. V.P.; C.F.O.; Fin. Admn.)

Piers C. Whitehead (V.P.; Bus. Devept.)

Franklin M. Berger (Dir.,)

Dividend

Ex-Dividend Date: N/A

Annual Dividend: N/A

Current Dividend Yield: N/A

Dividend Paid (3 months): N/A

Indicated Dividend: N/A

Earnings

Last Earnings Date: 9/30/2007

Next Earnings Date(Expected): 12/5/2009

Mean EPS (Next Qtr): ($0.01)

Mean EPS (Year): ($0.01)

Mean Estimate(Long Term): ($0.01)

P/E Ratio(Based on EPS estimate): -0.010

Number of Estimates: 0

Shares Performance

Period	VXGN	Compare to S&P
YTD	51.16 %	25.09 %
4 Weeks	22.64 %	16.43 %
12 Weeks	6.56 %	-0.77 %

Shares Information

Analyst Coverage: N

Avg Volume: 163205

Shares Outstanding: 33M

Market Cap: $0.02B

52 Week High: $0.74

52 Week Low: $0.33

P/E Ratio: -0.010

PEG Ratio: -0.010

Split: On 1/1/1990 VXGN split by factor of 2.000

Earnings Performance

EPS Growth in Last Quarter: -0.01 %

EPS Growth in Last Year: -0.01 %

Sales Growth in Last Quarter: -0.01 %

Sales Growth in Last Quarter: -95.31 %

Financials

Qtr Book Value: $0.70

Cash Flow/Share: ($0.01)

Change in Payout Ratio: -0.010

Price/Sales: -0.010